Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Journal of Clinical Trials|June 24, 2024
Study Protocol for a Randomized Controlled Trial of Low Intensity Shockwave Therapy for the Treatment of Post-Radical Prostatectomy Erectile Dysfunction: "SHARP-ED TRIAL"Francis Petrella, Braian R Ledesma, David Velasquez, et al.
International Journal of Impotence Research|July 29, 2023
Exploring representation of underrepresented minority men in a restorative therapy clinical trial for erectile dysfunction: addressing barriers and promoting inclusionBraian R Ledesma, Jamie Thomas, Armin Ghomeshi, et al.
Scientific Reports|October 5, 2018
Kidney-derived c-kit+ progenitor/stem cells contribute to podocyte recovery in a model of acute proteinuriaErika B Rangel, Samirah A Gomes, Rosemeire Kanashiro-Takeuchi, et al.
Frontiers in Physiology|October 17, 2019
Mesenchymal Stem Cell Secretion of SDF-1α Modulates Endothelial Function in Dilated CardiomyopathyCourtney Premer, Amarylis Wanschel, Valeria Porras, et al.
The Journal of Sexual Medicine|February 16, 2020
The Effect of Transendocardial Stem Cell Injection on Erectile Function in Men With Cardiomyopathy: Results From the TRIDENT, POSEIDON, and TAC-HFT TrialsJesse Ory, Russell G Saltzman, Ruben Blachman-Braun, et al.
Contemporary Clinical Trials Communications|January 29, 2021
Demographic representation in clinical trials for cell-based therapyRussell G Saltzman, Dushyantha T Jayaweera, Lina V Caceres, et al.
Sexual Medicine Reviews|June 6, 2023
The impact of cell-based therapy on female sexual dysfunction: a systematic review and meta-analysisRussell G Saltzman, Katherine G Campbell, Sarah J Ripps, et al.
Stem Cells Translational Medicine|May 26, 2025
Long term event-free survival following cell-based therapy in patients with cardiomyopathy: the HYPERION observational cohortRussell G Saltzman, Andrew Sundin, Lina V Caceres, et al.
Biorxiv : the Preprint Server for Biology|July 17, 2025
Cardiomyocyte-specific expression of HIF-1α mediates the cardioprotective effects of Growth Hormone Releasing Hormone (GHRH)Rosemeire M Kanashiro-Takeuchi, Lauro M Takeuchi, Wayne Balkan, et al.
American Heart Journal|December 15, 2025
Design and rationale of CATO, a Phase IIA, randomized, double-blind, placebo-controlled study of single or repeated intravenous administration of umbilical cord-derived mesenchymal stromal cells in ischemic cardiomyopathyRoberto Bolli, Xian-Liang Tang, Joshua M Hare, et al.
Pageof 3